The right CRO has real expertise in your product type, therapeutic area and regulatory pathway, whether that is EU MDR 2017/745 for devices or IVDR 2017/746 for in-vitro diagnostics. This guide walks through what to weigh: quality certifications, clinical capabilities, cost transparency, and global versus boutique.
Choosing the right partner starts with understanding what a specialist medical device CRO in Europe actually delivers, from clinical investigation and CER to PMCF under the EU MDR.
Platinum Award 2026
Top prize in the xShare x European CRO Federation "EHDS & Clinical Research" Open Call, awarded to Eclevar MedTech and its Milo Health platform, presented at the EUCROF 2026 conference in Amsterdam.
Horizon Europe · Grant Agreement No. 101136734 · Amsterdam, 2 Feb 2026
Device and diagnostic leaders rely on Eclevar to run compliant clinical programmes. Read all client success stories.
Medical device and diagnostic companies increasingly partner with CROs to accelerate development and secure regulatory compliance. A clinical research organisation should ideally have proven expertise in your product type and therapeutic area, and demonstrated success on the exact regulatory pathway you face, whether device conformity under EU MDR regulatory strategy or performance evaluation under IVDR 2017/746.
Demonstrated experience with your category, be it a device, an IVD or software as a medical device, and the matching pathway under MDR, IVDR or 510(k). Former competent authority and notified body reviewers add real navigation value.
Recognised certifications and compliance documentation, plus the professional qualifications of the project leadership and executive team who will actually run your study.
An established network and regional partnerships, clear itemised cost structures with defined pass-through expenses, and minimal project management turnover so knowledge stays in the team.
Dr Mark DaCosta, COO and former TÜV SÜD reviewer, leads a team that has sat on the other side of conformity assessment. That perspective shapes how we design device programmes under EU MDR 2017/745 and diagnostic programmes under IVDR 2017/746, supported by dedicated IVD experts and in-house CRAs rather than outsourced monitoring.
Weigh these together rather than in isolation. The strongest partnerships score well on quality, capability, regulatory depth and continuity at once, aligned to your MDR technical review and regulatory services.
Recognised certifications show a commitment to rigorous standards across every project phase.
Assess the operational reach that will carry your study end to end.
Cost matters, but it should not drive the decision on its own.
Depth on your exact pathway, with personnel from former competent authority or notified body backgrounds and a current read on evolving MDR and IVDR requirements, including SaMD.
Consistent team membership across the study preserves institutional knowledge, shortens learning curves and improves outcomes.
Domain knowledge in areas such as cardiovascular, orthopaedics or wound care ensures a nuanced grasp of product-specific requirements.
Three certifications establish credibility, and full-service capability keeps everything under one accountable roof rather than spread across several vendors.
The method parallels general device CRO evaluation, but diagnostics carry specific regulatory and technical requirements under IVDR 2017/746. Operations teams ideally need project managers and CRAs with direct IVD experience to address these appropriately. Eclevar maintains dedicated IVD experts for this segment.
Specialists in IVDR 2017/746 frameworks and in-vitro diagnostic compliance, able to navigate the diagnostic approval pathway rather than treating it as a device add-on.
Project managers and clinical research associates with direct IVD backgrounds, and an understanding of diagnostic-specific study design requirements.
Analytical validation, performance evaluation and clinical performance study design for diagnostics, with diagnostic-specific protocol development expertise.
Both models can work. The question is which one fits a device or IVD programme where nuance and team continuity matter.
Fix your product type, therapeutic area and pathway under EU MDR or IVDR 2017/746.
Verify ISO 14155, ISO 13485 and ISO 9001, plus leadership qualifications.
Check global reach, CTMS and EDC, and evidence via clinical evaluation and real-world evidence and PMCF.
Run a standardised RFI / RFP, compare line items and interrogate pass-through costs.
Confirm team stability, direct leadership access and, for IVDs, dedicated IVD experts.
Prioritise a CRO with proven expertise in your product type and therapeutic area, the right regulatory pathway experience under EU MDR 2017/745 or IVDR 2017/746, recognised quality certifications, a stable project team with low turnover, transparent itemised costs, and access to leadership. Former competent authority and notified body reviewers add real value when navigating conformity assessment.
Look for ISO 14155 for the clinical investigation of medical devices in human subjects, ISO 13485 for medical device quality management, and ISO 9001 for general quality management. Together they show a CRO maintains rigorous quality and regulatory compliance across every project phase.
The method is broadly the same, but IVD work carries specific regulatory and technical distinctions. Choose a CRO with dedicated specialists in IVDR 2017/746, project managers and CRAs with direct IVD experience, and expertise in performance evaluation, analytical validation and clinical performance study design for diagnostics. Eclevar maintains dedicated IVD experts for this segment.
Large global CROs built on pharmaceutical trials do not always translate that experience to device and IVD nuances, and can bring resource sharing, project manager turnover and added cost layers. Boutique device and diagnostic CROs offer full focus on device and IVD trials, stable teams, direct access to leadership and lean cost structures, which often delivers more responsive, personalised service.
Compare unit rates and itemised line items rather than a single aggregate figure, request a clear breakdown of pass-through expenses that can significantly affect total cost, confirm every study specification is included, and treat unusually low bids with caution. A standardised RFI or RFP framework keeps every proposal on a like-for-like basis.
Talk to our team about your product type, your pathway under EU MDR 2017/745 or IVDR 2017/746, and how a focused CRO with dedicated IVD experts can deliver better value than cost alone.
Book a free consultation